During the past decade, medius KLINIK NÜRTINGEN conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "medius KLINIK NÜRTINGEN" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "medius KLINIK NÜRTINGEN" are "Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Colitis, Ulcerative" (1 trials), "Crohn's Disease" (1 trials), "Extensive-stage Small Cell Lung Cancer" (1 trials) and "HER2-negative Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "medius KLINIK NÜRTINGEN" in a lesser frequency.

Most popular intervention types in "medius KLINIK NÜRTINGEN" are "Drug" (4 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Golimumab" (2 trials), "Guselkumab" (2 trials), "JNJ-78934804" (2 trials) and "Abemaciclib + Aromatase Inhibitor" (1 trials). Other intervention names were less common.

The vast majority of trials in "medius KLINIK NÜRTINGEN" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "medius KLINIK NÜRTINGEN". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in medius KLINIK NÜRTINGEN, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in medius KLINIK NÜRTINGEN, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".